Search Results for: FORMULATION DEVELOPMENT TECHNOLOGY A Novel
Articles
Adamis Pharmaceuticals Signs Agreement to Acquire 3M’s Technology August 11, 2013
Adamis Pharmaceuticals Corporation recently announced it has entered into an agreement to exclusively license and, with additional payment, fully acquire...LIPOSOME PREPARATION TECHNOLOGY - Freeze Fracture Electron Microscopic (ff EM) Examination & Analysis of Liposomes Produced by Covaris AFA Technology June 10, 2013
Srikanth Kakumanu, PhD, and Rajeev A. Jain, PhD, explain how an alternative ultrasonic processing technology allows manufacturing of liposomes of predetermined sizes and offers an efficient, isothermal, and non-contact process.
ORALLY DISINTEGRATING TABLETS - Novel Controlled Release Formulation for Orally Disintegrating Tablets Using Ion Exchange Resins June 10, 2013
Abhijit Gokhale, PhD, and Praba Sundararajan indicate that drugs not typically amenable to ODT formulations include those that present taste-masking difficulties or require controlled or sustained release. However, as the demand for ODTs continues to grow, formulation scientists are exploring ways to adapt ODT formulations for drugs that require controlled or sustained release for optimal therapeutic benefits.
Recipharm & Synthonics Join Forces to Promote Delivery Technology May 14, 2013
Recipharm Pharmaceutical Development AB and Synthonics, Inc. recently announced the formation of a Joint Promotion Agreement. The contract, the first...Imugene Granted Patent for Novel Delivery Technology May 6, 2013
Australian drug delivery technology company Imugene recently announced the acceptance of a key Chinese patent application for the company’s novel...FORMULATION DEVELOPMENT - Trends & Opportunities in Particle Design Technologies - Life Sciences & Biopharma in the Spotlight April 30, 2013
Frost & Sullivan Analyst, Cecilia Van Cauwenberghe, MS, examines the observed trends in particle design and engineering technologies, as well as the main factors and opportunities driving the principal technological advances in the biopharmaceutical industry.
ADVANCED DELIVERY DEVICES - IntelliCap: An Intelligent, Electronic Capsule for Oral Drug Delivery & Development March 31, 2013
Jeff Shimizu and Christoph Wanke, PhD, indicate electronic smart pills represent an emerging area with great potential for growth. Already established in the diagnostic area, the next move is into monitoring and drug delivery.
INNOVATION AWARDS - Drug Delivery Award Winners Move Innovation Needle; Formulation Takes Center Stage March 31, 2013
Marc Dresner presents the three companies that were honored by their industry peers with prestigious awards for breakthrough drug delivery innovation at the Institute for International Research’s 17th annual Drug Delivery Partnerships conference.
SPECIAL REPORT - Outsourcing Formulation Development and Manufacturing: An Early Approach Saves Time and Money March 31, 2013
In this Special Report, Contributor Cindy H. Dubin asks many of the leading companies in this sector what challenges pharma currently faces in formulation and manufacturing and how they, as third-party providers, are helping to alleviate those burdens.
FORMULATION DEVELOPMENT - Bioavailability Enhancement Strategies & Opportunities March 13, 2013
Frost & Sullivan Analyst Ruplekha Choudhurie reviews some BA approaches that are being developed by a number of companies that can mitigate the biological, physical, and chemical barriers for effective delivery of poorly soluble and permeable drugs.
DRUG DELIVERY - Oral Delivery of Peptides by Peptelligence Technology March 12, 2013
William Stern, PhD; Nozer Mehta, PhD; and Stephen Carl, PhD; review a highly developed, clinically proven platform technology that enables the oral delivery of peptides, overcoming the hurdles inherent to oral peptide delivery.
Xceleron & Crystal Pharmatech Announce Strategic Development Partnership January 21, 2013
Xceleron recently announced a partnership that will offer drug developers early bioavailability data that will lead to optimized solid-state...ALS Therapy Development Institute & to-BBB Collaborate on Motor Neuron Disease January 14, 2013
The ALS Therapy Development Institute (ALS TDI) recently announced it has entered into a new collaboration with to-BBB to...Pearl Therapeutics Issued US Patent on Co-Suspension Formulation Technology December 10, 2012
Pearl Therapeutics Inc. recently announced that the US Patent and Trademark Office has issued a patent on its novel co-suspension...New Technology for Producing Thermostable Vaccines November 29, 2012
Bend Research Inc., PATH, and Fraunhofer USA Center for Molecular Biotechnology (FhCMB) recently announced the development of a new technology...Tekmira Acquires Worldwide License to Novel RNAi Technology November 29, 2012
Tekmira Pharmaceuticals Corporation recently announced it has obtained a worldwide, non-exclusive license to a novel RNAi payload technology called Unlocked...Catalent Licenses Innovative Technology October 11, 2012
Following a successful research collaboration, Catalent Pharma Solutions recently announced it has taken an exclusive license to innovative taste-masking...Novozymes Now Supplying Hyasis, a Novel Pharmaceutical-Grade HA May 14, 2012
Novozymes Biopharma, part of Novozymes A/S, recently announced the first shipment of the company's Bacillus-derived hyaluronic acid, Hyasis, from its...Bend Research Technology Helps Advance Promising Compound March 15, 2012
Bend Research Inc. recently announced a licensing agreement with Affinium Pharmaceuticals, Ltd in which Bend has licensed its proprietary spray-dried...Zogenix & Battelle to Collaborate on Advanced Drug Delivery Technology January 29, 2012
Zogenix, Inc. and Battelle recently announced a unique collaboration with the objective of advancing the development and commercialization of Zogenix's...Company Profiles
Lyophilization Technology, Inc.
Lyophilization Technology, Inc. 30 Indian Drive Ivyland, PA 18974-1431 T: (215) 396-8373 F: (215) 396-8375 E: inquiry@lyo-t.com W: www.lyotechnology.com WHO...DRUG-DEVICE DEVELOPMENT - Exploring the Complexities of Drug-Device Combination Products
Jeremy Guo, Senior Vice President at WuXi Biologics, and colleagues explain that many factors need to be taken into account when producing a Drug-Device Combination Product from development testing to fill/finish and assembly.
